Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Since the relapse rate of DLBCL to frontline chemoimmunotherapy and salvage autologous hematopoietic cell transplant is high, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was adopted. Given the tim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Part Ther
Hauptverfasser: Saifi, Omran, Kharfan-Dabaja, Mohamed A., Zeidan, Youssef H., Peterson, Jennifer, Rule, William G., Lester, Scott C., Hoppe, Bradford S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Particle Therapy Co-operative Group 2020
Schlagworte:
Review Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7574825/
https://ncbi.nlm.nih.gov/pubmed/33094131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14338/IJPT-20-00004.1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge